15.01.2015 Views

CST Guide:

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Section I: Research Areas<br />

chapter 02: Signaling<br />

ALK, an RTK that forms oncogenic fusion proteins with<br />

EML4, TFG, and KIF5B, is expressed in lung carcinoma.<br />

ALK (D5F3 ® ) XP ® Rabbit mAb #3633: IHC<br />

analysis of paraffin-embedded human lung<br />

carcinoma with high (left) and low (right) levels<br />

of ALK expression using #3633.<br />

Phospho-Jak2 (Tyr1008) (D4A8) Rabbit<br />

mAb #8082: WB analysis of extracts from<br />

BaF3 cells (A), untreated or treated with Mouse<br />

Interleukin-3 (mIL-3) #8923 (10 ng/ml, 5 min),<br />

using #8082 (upper) or total Jak2 (D2E12) XP ®<br />

Rabbit mAb #3230 (lower).<br />

Jak2 (D2E12) XP ® Rabbit mAb #3230:<br />

Confocal IF analysis of K-562 cells (B) using<br />

#3230 (green). Blue pseudocolor = DRAQ5 ®<br />

(fluorescent DNA dye).<br />

A<br />

kDa<br />

200<br />

140<br />

100<br />

80<br />

60<br />

50<br />

40<br />

30<br />

200<br />

140<br />

100<br />

Phospho-<br />

Jak2<br />

(Tyr1008)<br />

Jak2<br />

B<br />

Treatment with<br />

IL-3 results in<br />

phosphorylation<br />

of Jak2 at Tyr1008.<br />

80<br />

60<br />

50<br />

40<br />

Ligand activation of<br />

Met, a high affinity RTK<br />

for hepatocyte growth<br />

factor (HGF), results<br />

in phosphorylation at<br />

Tyr1234/1235.<br />

A kDa<br />

200<br />

140<br />

100<br />

80<br />

60<br />

50<br />

40<br />

Phospho-Met<br />

(Tyr1234/5)<br />

B<br />

Phospho-Met (Tyr1234/1235) (D26) XP ® Rabbit mAb #3077: WB analysis of cell<br />

extracts from HeLa cells, untreated or stimulated with HGF (A), using #3077 (upper) and Met<br />

(25H2) Mouse mAb #3127 (lower). Confocal IF analysis of MKN-45 cells, untreated (B) or<br />

treated with SU11274 (1 μM, 3 hr) (C), using #3077. Blue pseudocolor = DRAQ5 ® #4084<br />

(fluorescent DNA dye).<br />

C<br />

Treatment with a<br />

Met inhibitor prevents<br />

Met activation and<br />

phosphorylation at<br />

Tyr1234/1235.<br />

The nonreceptor tyrosine kinase<br />

Zap-70 is expressed in T cells.<br />

30<br />

– +<br />

Zap-70 (D1C10E) XP ® Rabbit mAb (Alexa Fluor ® 488 Conjugate) #9473:<br />

Flow cytometric analysis of Ramos (B cells; blue) and Jurkat (T cells; green) cells<br />

using #9473.<br />

mIL-3<br />

Events<br />

Zap-70<br />

200<br />

140<br />

100<br />

80<br />

60<br />

50<br />

40<br />

– +<br />

Met<br />

HGF<br />

Nonreceptor Tyrosine Kinases<br />

The cytoplasmic nonreceptor tyrosine kinases transduce signals generated by RTKs and other receptors<br />

from the cell surface to the nucleus. Receptor-associated tyrosine kinases are phosphorylated within the<br />

activation loop of their kinase catalytic domain, resulting in activation and propagation of downstream<br />

signals through phosphorylation of other kinases, adaptor proteins, or transcription factors. In addition<br />

to their kinase domain, nonreceptor tyrosine kinases often contain various domains that mediate<br />

protein-protein or protein-lipid interactions, which allows association with activated receptors or downstream<br />

signaling nodes. For example, SH2 domains bind phospho-tyrosine residues, while PH domains<br />

direct interactions with membrane lipids.<br />

PDGF treatment results in phosphorylation<br />

of Src family proteins at Tyr416.<br />

Phospho-Src Family (Tyr416) (D49G4) Rabbit mAb #6943: WB analysis of extracts<br />

NIH/3T3 cells, serum-starved or treated with human Platelet-Derived Growth Factor BB<br />

hPDGF-BB #8912 (100 ng/ml, 15 min), using #6943 (upper) or Src (36D10) Rabbit mAb<br />

#2109 (lower).<br />

Select Reviews<br />

Arteaga, C.L. and Engelman, J.A. (2014) Cancer Cell 25, 282−303. • Davies, K.D. and Doebele, R.C. (2013) Clin. Cancer<br />

Res. 19, 4040−4045. • Hallberg, B. and Palmer, R.H. (2013) Nat. Rev. Cancer 13, 685−700. • Liu, S.T., Pham, H., Pandol,<br />

S.J., and Ptasznik, A. (2014) Front. Physiol. 4, 416. • Miaczynska, M. (2013) Cold Spring Harb. Perspect. Biol. 5, a009035.<br />

• Panjarian, S., Lacob, R.E., Chen, S., Engen, J.R., and Smithgall, T.E. (2013) J. Biol. Chem. 288, 5443−5450. • Shaw, A.T.,<br />

Hsu, P.P., Awad, M.M., and Engelman, J.A. (2013) Nat. Rev. Cancer 13, 772−787.<br />

kDa<br />

100<br />

80<br />

60<br />

50<br />

40<br />

30<br />

20<br />

100<br />

80<br />

60<br />

50<br />

40<br />

30<br />

20<br />

– +<br />

Phospho-Src<br />

(Tyr416)<br />

Src<br />

hPDGF-BB<br />

Commonly Studied Tyrosine Kinases Targets<br />

Target M P E S C<br />

ACPP<br />

•<br />

ALK • • •<br />

Phospho-ALK (Tyr1078) • •<br />

Phospho-ALK (Tyr1096) • •<br />

Phospho-ALK (Tyr1278) • •<br />

Phospho-ALK (Tyr1282/Tyr1283) • •<br />

•<br />

Phospho-ALK (Tyr1278/Tyr1282/<br />

Tyr1283)<br />

Phospho-ALK (Tyr1586) • • •<br />

Phospho-ALK (Tyr1604) • • •<br />

Axl<br />

• • • •<br />

Phospho-Axl (pan Tyr)<br />

•<br />

Phospho-Axl (Tyr702) •<br />

DDR1<br />

• • •<br />

Phospho-DDR1 (pan Tyr)<br />

•<br />

Phospho-DDR1 (Tyr792) •<br />

DDR2<br />

•<br />

EGFR<br />

• • • • •<br />

Phospho-EGFR (Thr669) • •<br />

Phospho-EGFR (Tyr845) • • •<br />

Phospho-EGFR (Tyr992) •<br />

Phospho-EGFR (Tyr998) •<br />

Phospho-EGFR (Tyr1045) •<br />

Phospho-EGFR (Ser1046/1047) •<br />

Phospho-EGFR (Tyr1068) • • • •<br />

Phospho-EGFR (Tyr1086) •<br />

Phospho-EGFR (Tyr1148) •<br />

Phospho-EGFR (Tyr1173) • •<br />

• • •<br />

EGF Receptor<br />

(E746-A750del Specific)<br />

Target M P E S C<br />

EGF Receptor (L858R Mutant Specific) • •<br />

EphA2<br />

•<br />

Phospho-EphA2 (Tyr588) •<br />

Phospho-EphA2 (Tyr594) •<br />

Phospho-EphA2 (Tyr772) •<br />

Phospho-EphA2 (Ser897) •<br />

Phospho-EphA3 (Tyr779) •<br />

EphA3/EphA4/EphA5 •<br />

EphB1<br />

•<br />

EphB6<br />

•<br />

Phospho-Ephrin B (Tyr324/329) •<br />

Eps8<br />

•<br />

EREG<br />

•<br />

Etk/BMX<br />

•<br />

Phospho-Etk/BMX (Tyr40) •<br />

FGFR1 • • • •<br />

FGFR1 (pan Tyr)<br />

•<br />

FGFR1 (Tyr653/Tyr654) • • •<br />

FGFR1 (Tyr766)<br />

•<br />

FGFR2 • • •<br />

Phospho-FGFR2 (Pan Tyr)<br />

•<br />

FGFR3<br />

•<br />

FGFR4 • • • •<br />

FLT3 • •<br />

Phospho-FLT3 (pan Tyr)<br />

•<br />

Phospho-FLT3 (Tyr589/Tyr591) •<br />

Phospho-FLT3 (Tyr591) • • •<br />

Phospho-FLT3 (Tyr842) •<br />

Phospho-FLT3 (Tyr969) •<br />

HER2/ErbB2<br />

• • • • •<br />

These protein targets represent key<br />

nodes within tyrosine kinases signaling<br />

pathways and are commonly studied<br />

in tyrosine kinases research. Primary<br />

antibodies, antibody conjugates, and<br />

antibody sampler kits containing these<br />

targets are available from <strong>CST</strong>.<br />

Listing as of September 2014. See our<br />

website for current product information.<br />

M Monoclonal Antibody<br />

P Polyclonal Antibody<br />

E PathScan ® ELISA Kits<br />

S SignalSilence ® siRNA<br />

C Antibody Conjugate<br />

68 For Research Use Only. Not For Use in Diagnostic Procedures. See pages 302 & 303 for Pathway Diagrams, Application, and Reactivity keys.<br />

www.cellsignal.com/csttyrosine 69

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!